Knight Initiative News

This week on the podcast, Stanford psychiatry professor Erin Gibson joins us again to share the latest findings on sleep, myelin, and neurodegenerative disease.

This week on the podcast, Stanford neurobiologist Robert Sapolsky lays out his view that we should stop judging one another (and ourselves) for behaviors we can't control

We're diving back into the world of psychedelic medicine with anesthesiologists Boris Heifets and Theresa Lii, who share intriguing new data that sheds light on how ketamine and placebo effects may interact in treating depression.

Today, we are going back into the archives for a conversation with neuroscientist, entrepreneur, and best-selling author David Eagleman about the science of synesthesia. If you don't know what that is, you're about to find out.

This week, we talk with our founding director, Bill Newsome, about the 10-year legacy of the NIH BRAIN Initiative and the uncertainty for the future brought on by this year's dramatic funding cuts.

This week we are talking with Stanford neuroscientist Ivan Soltesz about endocannabinoids, illuminating the "day job" of these unusual neurotransmitters and how they may be hijacked by cannabinoid drugs such as THC and CBD.

This week we are talking with Stanford neurobiologist Lisa Giocomo, exploring the intersection of memory, navigation, and the boundaries we create between ourselves and the world around us.

This week on From Our Neurons to Yours, we talk with Stanford neurologist Mike Greicius about his critique of new amyloid-clearing Alzheimer's drugs, and his optimism for the next wave of therapies currently in development.

This week on From Our Neurons to Yours, we talk with Leanne Williams about distinctive biotypes of depression revealed by brain imaging and AI, and the implications for therapy and mental health.

This week on From Our Neurons to Yours, we talk with Michelle Monje about her discovery that many cancers depend on nervous system innervation; she also discusses opportunities for novel therapies.

This week on From Our Neurons to Yours, we talk with Sergiu Pasca about using new techniques for growing human brain tissue in the lab to solve a rare neurological disorder.

This week, we talk with "radical behaviorist" Kim Bullock about how virtual reality technologies could serve as behavioral therapeutics to enhance psychotherapy.

This week, we talk with Zhenan Bao about reverse engineering the remarkable properties of human skin to design new wearable devices for neuroscience.

This week, we talk with Michelle Monje and Rob Malenka about recent findings on the role of myelin plasticity in opioid addiction.

Why do our brains get worse at learning as we get older, and what can we do about it? Institute affiliate Carla Shatz discusses our brain's capacity for change on this podcast episode.

This week, we talk with Surya Ganguli about the neuroscience of AI, and how advances in artificial intelligence could teach us about our own brains.

This week on From Our Neurons to Yours, we talk with memory expert Anthony Wagner about the nature of memory and how to improve it.

This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about how psychedelics work in the brain.

This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about studies that could change our understanding of the renaissance in psychedelic medicine.

This week on From Our Neurons to Yours, we're talking about the neuroscience of climate change with neuroeconomist Nik Sawe.